Buyout Firms Among Suitors for AstraZeneca Unit
Private equity firms Bridgepoint, Cinven, PAI Partners and Warburg Pincus had all joined the first round of bidding for AstraZeneca's dental implants and medical devices division Astra Tech, Reuters reported, citing a report by the Mail on Sunday newspaper. The firms are competing with U.S. orthopaedic devices maker Zimmer for the unit. The sale is expected to fetch about 1.3 billion pounds ($2.1 billion).



